• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞-胆管细胞癌合并症。4例的细胞学检查结果

Combined hepatocellular-cholangiocarcinoma. Cytologic findings in four cases.

作者信息

Dusenbery D

机构信息

Department of Pathology, University of Pittsburgh Medical Center, Pennsylvania 15213-2582, USA.

出版信息

Acta Cytol. 1997 May-Jun;41(3):903-9. doi: 10.1159/000332726.

DOI:10.1159/000332726
PMID:9167724
Abstract

BACKGROUND

Rarely do primary hepatic tumors show mixed hepatocellular carcinoma (HCC) and cholangiocarcinoma differentiation. Histologic criteria for these combined hepatocellular-cholangiocarcinomas (CHCC-C) are not universally agreed upon. Cytologic descriptions of CHCC-C are scarce, yet recognition of this tumor type may have some prognostic significance.

CASES

The clinical and cytohistologic findings, including histochemical and immunohistochemical studies, in four cases of CHCC-C were reviewed. The specimens consisted of three needle biopsies of the liver and one bile duct brushing specimen. In all cases the diagnosis of CHCC-C was confirmed by histologic, histochemical and immunohistochemical study.

CONCLUSION

The reliable diagnosis of CHCC-C on cytologic preparations alone is fraught with difficulty. However, the addition of cell block or core biopsy histologic material, which may serve as a substrate for histochemical and immunohistochemical studies, may permit the diagnosis to be made. Serum markers of HCC, when elevated, may raise the suspicion of hepatocellular differentiation even when it is not suspected based on examination of the cytologic and/or histologic biopsy specimen.

摘要

背景

原发性肝肿瘤很少表现出肝细胞癌(HCC)和胆管癌的混合分化。对于这些联合性肝细胞-胆管癌(CHCC-C)的组织学标准尚未达成普遍共识。CHCC-C的细胞学描述很少见,然而,识别这种肿瘤类型可能具有一定的预后意义。

病例

回顾了4例CHCC-C的临床及细胞组织学检查结果,包括组织化学和免疫组织化学研究。标本包括3例肝脏穿刺活检和1例胆管刷检标本。所有病例均经组织学、组织化学和免疫组织化学研究确诊为CHCC-C。

结论

仅依靠细胞学涂片可靠诊断CHCC-C存在困难。然而,增加细胞块或芯针活检组织学材料,可作为组织化学和免疫组织化学研究的底物,有助于做出诊断。HCC的血清标志物升高时,即使根据细胞学和/或组织学活检标本检查未怀疑有肝细胞分化,也可能增加对肝细胞分化的怀疑。

相似文献

1
Combined hepatocellular-cholangiocarcinoma. Cytologic findings in four cases.肝细胞-胆管细胞癌合并症。4例的细胞学检查结果
Acta Cytol. 1997 May-Jun;41(3):903-9. doi: 10.1159/000332726.
2
Differential diagnosis of malignant epithelial tumours in the liver: an immunohistochemical study on liver biopsy material.肝脏恶性上皮性肿瘤的鉴别诊断:肝活检组织的免疫组织化学研究。
Ann Hepatol. 2011 Oct-Dec;10(4):508-15.
3
Combined hepatocellular-cholangiocarcinoma. Diagnostic challenge in hepatic fine needle aspiration biopsy.肝细胞-胆管细胞癌合并症。肝脏细针穿刺活检中的诊断挑战。
Acta Cytol. 1999 Mar-Apr;43(2):131-8. doi: 10.1159/000330966.
4
The clinical characteristics and prognostic factors of combined Hepatocellular Carcinoma and Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma after Surgical Resection: A propensity score matching analysis.肝细胞癌合并胆管细胞癌、肝细胞癌和肝内胆管细胞癌术后的临床特征和预后因素:倾向评分匹配分析。
Int J Med Sci. 2021 Jan 1;18(1):187-198. doi: 10.7150/ijms.50883. eCollection 2021.
5
Comparative analysis of immunohistochemical markers for differential diagnosis of hepatocelluar carcinoma and cholangiocarcinoma.用于肝细胞癌和胆管癌鉴别诊断的免疫组化标志物的比较分析
Tumori. 2012 Jul-Aug;98(4):478-84. doi: 10.1177/030089161209800413.
6
The diagnostic value of arginase-1 immunostaining in differentiating hepatocellular carcinoma from metastatic carcinoma and cholangiocarcinoma as compared to HepPar-1.arginase-1 免疫染色在鉴别肝细胞癌与转移性癌和胆管细胞癌中的诊断价值与 HepPar-1 相比。
Diagn Pathol. 2012 Oct 30;7:149. doi: 10.1186/1746-1596-7-149.
7
Pathology of combined hepatocellular-cholangiocarcinoma.混合性肝细胞肝癌的病理学。
J Gastroenterol Hepatol. 2010 Sep;25(9):1485-92. doi: 10.1111/j.1440-1746.2010.06430.x.
8
Cytologic features of fibrolamellar carcinoma with mucin production: a rare variant of combined hepatocellular-cholangiocarcinoma.伴有黏液产生的纤维板层癌的细胞学特征:一种罕见的肝细胞-胆管癌联合变体。
Diagn Cytopathol. 2014 May;42(5):431-5. doi: 10.1002/dc.22931. Epub 2012 Sep 25.
9
Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis.肝细胞癌合并胆管细胞癌:临床特征、治疗方式和预后。
Ann Surg Oncol. 2012 Sep;19(9):2869-76. doi: 10.1245/s10434-012-2328-0. Epub 2012 Mar 27.
10
[Evaluation of immunohistochemical markers for differential diagnosis of hepatocellular carcinoma from intrahepatic cholangiocarcinoma].[用于肝细胞癌与肝内胆管癌鉴别诊断的免疫组化标志物评估]
Zhonghua Zhong Liu Za Zhi. 2008 Sep;30(9):702-5.

引用本文的文献

1
Bile duct involvement by hepatocellular carcinoma: A rare occurrence and poor prognostic indicator in bile duct brushing samples.肝细胞癌累及胆管:胆管刷检样本中罕见的发生情况及不良预后指标。
Cancer Cytopathol. 2019 Nov;127(11):691-699. doi: 10.1002/cncy.22185. Epub 2019 Sep 13.
2
Clinical features, histology, and histogenesis of combined hepatocellular-cholangiocarcinoma.肝细胞-胆管细胞癌的临床特征、组织学及组织发生
World J Hepatol. 2017 Feb 28;9(6):300-309. doi: 10.4254/wjh.v9.i6.300.
3
Combined hepatocellular cholangiocarcinoma: Controversies to be addressed.
肝细胞胆管癌合并症:有待解决的争议。
World J Gastroenterol. 2016 May 14;22(18):4459-65. doi: 10.3748/wjg.v22.i18.4459.
4
Fine-needle aspiration biopsy of hepatocellular carcinoma and related hepatocellular nodular lesions in cirrhosis: controversies, challenges, and expectations.肝硬化中肝细胞癌及相关肝细胞结节性病变的细针穿刺活检:争议、挑战与期望
Patholog Res Int. 2011;2011:587936. doi: 10.4061/2011/587936. Epub 2011 Jun 30.